PrivilEdge Graham Quant Macro MD Fonds
Anlageziel
The Sub-Fund is actively managed and is not managed in reference to a benchmark. The Sub-Fund’s objective is to achieve long-term investment returns by investing in a directional, long and short strategy that utilizes fundamental and price-based indicators to establish return forecasts across global interest rates, foreign exchange and stock indices. Quantitative risk management and portfolio construction techniques are used to diversify risk across the portfolio and seek to enhance risk-adjusted returns. The strategy is designed to have low correlation to traditional markets and other alternative strategies and has the potential to provide significant portfolio diversification benefits.
Stammdaten
Name | PrivilEdge Graham Quant Macro MD USD Inc Fonds |
ISIN | LU2211666719 |
WKN | A2QAD1 |
Fondsgesellschaft | JP Morgan Asset Management (UK) Ltd |
Benchmark | Kein Benchmark |
Ausschüttungsart | Ausschüttend |
Manager | Not Disclosed |
Domizil | Luxembourg |
Fondskategorie | Alternative |
Auflagedatum | 21.09.2022 |
Geschäftsjahr | 30.09. |
VL-fähig? | Nein |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | Bank Lombard Odier & Co Ltd. |
Riester Fonds | Nein |
Basisdaten
Auflagedatum | 21.09.2022 |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | Bank Lombard Odier & Co Ltd. |
Domizil | Luxembourg |
Geschäftsjahr | 30.09. |
Aktuelle Daten
Morningstar Rating | |
Aktueller Rücknahmepreis | 11,49 |
Anzahl Fonds der Kategorie | 270 |
Volumen der Tranche | 4,16 Mio. USD |
Fondsvolumen | 191,00 Mio. USD |
Total Expense Ratio (TER) | 1,32 |
Gebühren
Laufende Kosten | 1,66% |
Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 1,32% |
Transaktionskosten | 0,34% |
Depotbankgebühr | - |
Managementgebühr | 1,20% |
Rücknahmegebühr | - |
Ausgabeaufschlag | - |
Performancedaten
Veränderung Vortag | 0,03 |
WE seit Jahresbeginn | 2,94% |